About Samantha A Morris
Samantha Morris received her undergraduate degree in Biochemistry from Imperial College of Science, Technology, and Medicine, University of London, UK. She then earned her Ph.D. from the University of Cambridge, UK, where she researched endoderm fate specification in Xenopus laevis development. Samantha then remained in Cambridge as a Research Fellow, joining the laboratory of Magdalena Zernicka-Goetz (Gurdon Institute, Cambridge) to investigate early mammalian fate specification. Her work on early cell fate plasticity spurred an interest in manipulating cell fate for therapeutic purposes. In pursuit of this, Samantha joined the laboratory of George Daley at Boston Children’s Hospital and Harvard Medical School, where she focused on analysis of gene regulatory networks to dissect and engineer cell fate. Samantha joined the Departments of Genetics, and Developmental Biology at WashU in July 2015. Her lab focuses on the development of new single-cell technologies to provide deeper insight into cell fate specification and reprogramming, enabling the engineering of clinically relevant cell populations.